19:50 EDT Passage Bio (PASG) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PASG:
- Passage Bio announces 1-for-20 reverse stock split
- Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
- Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
- Passage Bio Releases Promising Interim Data for PBFT02
- Passage Bio reports updated interim data from upliFT-D study of PBFT02